ALNY.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare
Comparison for ALNY, Alnylam Pharmaceuticals Inc
The comparison is made between ALNY and the comparison stocks RMT and BME
Sales
company | revenue | gross income | profit margin | income before tax |
---|---|---|---|---|
HQL | 29.56M | 26.97M | 91.24 | -11.45M |
RMT | 2.12M | 2.12M | 100.0 | 22.0M |
BME | 18.29M | 15.27M | 83.5 | 8.71M |
In the year ending in , Alnylam Pharmaceuticals Inc sales were $29.56 million and the highest and 189.75% higher than the average of $10.2 million After cost of goods, and selling and general costs, gross income were $26.97 million making it the highest and 210.25% higher than the average of $8.69 million The profit margin were a lot and 0.56% lower than the average of a lot
Assets
In the financial year , Alnylam Pharmaceuticals Inc net current assets were $5.05 million and 16.2% below the averarge of $6.02 million This consists of current assets, which were $5.05 million and 34.75% below the averarge of $7.73 million, less current liabilities, which were $0.0 the lowest of the comparisions and 100.0% lower than the average of $1712.19 thousandContributing to the current assets was Cash and Short term assets which were 0.01% making it the lowest and 100.0% lower than the average of $9.69, recievables (were 99.99% the highest of the comparisons and 88.06% higher than the average of 53.17%) and inventory (were 402.11% and above the other companies and a lot higher than the average of 0.0%) Contributing to the current liabilities were accounts payable (were nan,% and nan,% above the average of 9.79%) and short term debt (were nan,% and nan,% higher than the average of 79.73%)
As a multiple of net assets, current liabilities were 0.0% and the lowest and 100.0% lower than the average of 0.0. Current liabilities as days of sales represents were 0.0 making it the lowest and 100.0% lower than the average of 290.72.
In terms of days of sales, accounts receivables were 62.28 and 49.78% lower than the average of 124.01
Long term assets
For the year ending in , Alnylam Pharmaceuticals Inc net assets were $401.93 million making it the lowest and 27.49% lower than the average of $554.31 million This consists of current assets, which were $402.6 million and the lowest and 28.1% lower than the average of $559.98 million, less current liabilities, which were $666.96 thousand the lowest of the comparisions and 88.23% lower than the average of $5.67 million
Contributing to the total assets were Plant and Equipment (were 0.0% the same as the comparisions) and tangible assets(were 0.0% the same as the comparisions) Contributing to the total libiatilites were long term debt (were 0.0% the same as the comparisions) and
As a multiple of total assets, total liabilities were 0.17% and the lowest and 83.26% lower than the average of 0.01.
name | total assets | total liabs | cur assets | cur liabs | days AR |
---|---|---|---|---|---|
HQL | 402.6M | 666.96K | 5.05M | 0.0 | 62.28 |
RMT | 523.86M | 3.36M | 13.84M | 3.36M | 216.56 |
BME | 596.1M | 7.97M | 1620.87K | 60.69K | 31.46 |
Plots
``` ```